Back to top
more

Nu Skin Enterprises (NUS)

(Real Time Quote from BATS)

$7.47 USD

7.47
488,053

+0.24 (3.32%)

Updated Nov 13, 2024 02:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 10% (226 out of 250)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

4 Factors That Make The Estee Lauder (EL) a Promising Pick

by Zacks Equity Research

The Estee Lauder's (EL) impressive online business is driving growth. Also, the company's Skin Care portfolio is performing well.

Newell Brands (NWL) Beats Q4 Earnings & Sales Estimates

by Zacks Equity Research

Despite COVID-related woes, robust consumption patterns and higher demand for certain categories aided Newell Brands' (NWL) Q4 results.

Nu Skin (NUS) Tops Q4 Earnings Estimates, Raises Dividend

by Zacks Equity Research

Growth in sales leaders and customer base drove Nu Skin's (NUS) fourth-quarter 2020 results. Notably, earnings and revenues increased year over year.

Vrishali Bagree headshot

Coty (COTY) Stock Slips 15% Despite Q2 Earnings & Sales Beat

by Vrishali Bagree

Coty's (COTY) second-quarter fiscal 2021 results reflect lower earnings and sales due to the pandemic-related woes, especially in travel retail. However, e-commerce strength and cost-saving efforts aid.

NUS or HELE: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

NUS vs. HELE: Which Stock Is the Better Value Option?

Estee Lauder (EL) Q2 Earnings Beat Estimates, Sales Up Y/Y

by Zacks Equity Research

Estee Lauder's (EL) second-quarter fiscal 2021 sales and earnings increase year over year. However, results reflect impact of some retail store closures and lower traffic in reopened stores amid COVID-19.

Clorox (CLX) Q2 Earnings, Sales Top Estimates on Strong Demand

by Zacks Equity Research

Clorox's (CLX) Q2 sales benefit from double-digit sales growth in the majority of the segments, fueled by strong product demand due to the coronavirus outbreak and related shift in trends.

Zacks Industry Outlook Highlights: Estee Lauder, Helen of Troy, Coty, Nu Skin Enterprises and e.l.f. Beauty

by Zacks Equity Research

Zacks Industry Outlook Highlights: Estee Lauder, Helen of Troy, Coty, Nu Skin Enterprises and e.l.f. Beauty

Inter Parfums (IPAR) Ups 2020 Earnings View on Solid Q4 Sales

by Zacks Equity Research

Inter Parfums' (IPAR) sales increase year over year in fourth-quarter 2020. Management raises 2020 earnings guidance.

Vrishali Bagree headshot

5 Cosmetics Stocks Looking Good Amid Industry Challenges

by Vrishali Bagree

The Zacks Cosmetics industry is battling coronavirus woes like weak travel retail, reduced traffic and low makeup demand. However, high demand for personal care products bodes well for EL, HELE, COTY, NUS and ELF, which are focused on adapting to the changing market trends.

NUS or EL: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

NUS vs. EL: Which Stock Is the Better Value Option?

Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Procter & Gamble (PG) Q2 Earnings & Sales Beat, FY21 View Up

by Zacks Equity Research

Procter & Gamble's (PG) Q2 results gain from solid performance across all segments as well as a rise in organic shipment volumes, improved pricing and mix. Encouragingly, it lifts fiscal 2021 view.

3 Factors That Makes Helen of Troy (HELE) a Promising Pick

by Zacks Equity Research

Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, strength in the company's online business is yielding.

Inter Parfums' (IPAR) Subsidiary to Buy Office Building Complex

by Zacks Equity Research

Inter Parfums' (IPAR) subsidiary Interparfums SA to buy property in Paris, which will be used as its headquarters. Management expects to close the transaction during spring of 2021.

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

by Zacks Equity Research

Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Is (NUS) Outperforming Other Consumer Staples Stocks This Year?

Nu Skin (NUS) Looks Buoyant, Stock Up More Than 35% in a Year

by Zacks Equity Research

Nu Skin (NUS) has been benefiting from focus on innovation as well as commitment to strengthening sales leaders.

Estee Lauder (EL) Looks Solid on Online Business & Savings

by Zacks Equity Research

Estee Lauder (EL) is implementing new technology and digital experiences to boost online sales. Also, strength in the Skin Care category is driving growth.

Helen of Troy's (HELE) Q3 Earnings Beat Estimates, Sales Up Y/Y

by Zacks Equity Research

Helen of Troy's (HELE) third-quarter fiscal 2021 results reflect strength across the Beauty and the Health & Home segments along with gains in online business.

Is Nu Skin Enterprises (NUS) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

NUS vs. EL: Which Stock Is the Better Value Option?

by Zacks Equity Research

NUS vs. EL: Which Stock Is the Better Value Option?

Coty (COTY) Aids Beauty Categories With Kim Kardashian West Deal

by Zacks Equity Research

Coty (COTY) buys a 20% stake in Kim Kardashian West's business. The company's industry knowledge and Kim Kardashian West's robust following are likely to benefit both.

Nu Skin (NUS) Down 5.3% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Splunk (SPLK) Incurs Loss in Q3 Earnings, Revenues Down Y/Y

by Zacks Equity Research

Splunk's (SPLK) third-quarter fiscal 2021 results reflect growth in cloud revenues and customer base expansion despite decline in license revenues.